Walleye Capital’s Usana Health Sciences USNA Stock Holding History

Walleye Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66,269	Closed	-$1.3M	–	5020
2025 Q4	$1.3M	Sell	66,269 -63,068	-49%	-$1.31M	﹤0.01%	2217
2025 Q3	$3.56M	Buy	129,337 +83,508	+182%	+$2.57M	0.01%	1150
2025 Q2	$1.4M	Buy	45,829 +33,001	+257%	+$937K	0.01%	1787
2025 Q1	$346K	Buy	+12,828	New	+$406K	﹤0.01%	2846
2023 Q2	–	Sell	-4,409	Closed	-$277K	–	4901
2023 Q1	$277K	Buy	+4,409	New	+$263K	﹤0.01%	2195

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's USNA Position: Q1 2026 in Review

Walleye Capital sold out of Usana Health Sciences (USNA) in Q1 2026, closing a stake of 66,269 shares — an estimated $1.3M sold.

Walleye Capital first reported a position in USNA in Q1 2023 and held it in 5 quarters. The position peaked at $3.56M in Q3 2025. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

Walleye Capital reported no remaining Usana Health Sciences position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 66,269 Usana Health Sciences shares in Q1 2026, an estimated $1.3M.
Walleye Capital first reported a position in Usana Health Sciences in Q1 2023 and held it in 5 quarters.
Walleye Capital's Usana Health Sciences position peaked at $3.56M in Q3 2025.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.